Skip to main content
Equibles

PARMAX · Parmax Pharma Limited

Use PARMAX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PARMAX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
135.00 INR +1.30 (+0.97%) At close · Nov 9
Rebalance outlook locked
Market Cap
928.65M INR
Shares
6.88M
Volume · Nov 9 5648 Avg daily vol (3M) 7651

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close135.00 INR Open133.05 INR Day133.05–135.00 INR 52W close25.22–139.10 INR Avg vol 30d14K DataFeb 2020–Nov 2026

Quarterly results

Revenue Net income Net loss
· 48.26M INR −14.95M INR '25 Q4 · 19.42M INR −7.64M INR '26 Q1 · 25.31M INR −20.78M INR '26 Q2 · 43.26M INR −7.32M INR '26 Q3 ▼31.4% 33.13M INR −5.84M INR '26 Q4 LATEST ▲323.3% 82.21M INR 22.00M INR '27 Q1

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 25.22 INR Now 135.00 INR · 96% Range high 139.10 INR
vs 200-day avg +146% vs 50-day avg +21%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

5D 20D 120D MTD YTD
XBOM:PARMAX -3.0% +21.6% +351.5% 0.0% +299.1%

Exchange listing

Market
XBOM
Ticker
PARMAX
ISIN
INE240T01014
Security
Ordinary share
Trading currency
INR

Company

Website
https://parmaxpharma.com/
Investor relations
https://parmaxpharma.com/investor_relations.php

Other listings of this company

No other verified listings are available.

Recent dividends

No verified dividend payments are available for this listing yet.

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

No earnings calls have been captured for this company yet.